惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

V
V2EX
人人都是产品经理
人人都是产品经理
WordPress大学
WordPress大学
博客园 - Franky
小众软件
小众软件
酷 壳 – CoolShell
酷 壳 – CoolShell
Apple Machine Learning Research
Apple Machine Learning Research
爱范儿
爱范儿
IT之家
IT之家
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
V
Visual Studio Blog
S
SegmentFault 最新的问题
美团技术团队
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
有赞技术团队
有赞技术团队
B
Blog RSS Feed
Last Week in AI
Last Week in AI
Jina AI
Jina AI
博客园 - 司徒正美
The Cloudflare Blog
博客园_首页
博客园 - 聂微东
宝玉的分享
宝玉的分享
大猫的无限游戏
大猫的无限游戏

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Talphera, Inc. (TLPH) Q1 2026 Earnings Call Transcript
2026-05-14 · via All Articles on Seeking Alpha

Talphera, Inc. (TLPH) Q1 2026 Earnings Call May 13, 2026 4:30 PM EDT

Company Participants

Raffi Asadorian - Chief Financial Officer
Vincent Angotti - CEO & Director
Shakil Aslam - Chief Medical Officer

Conference Call Participants

Matthew Venezia - Alliance Global Partners, Research Division
Antonio Arce - WestPark Capital, Inc.

Presentation

Operator

Welcome to the Talphera First Quarter 2026 Financial Results Conference Call. This call is being webcast live via the Events page of the Investors section of Talphera's website at www.talphera.com. You may listen to a replay of this webcast by going to the Investors section of Talphera's website.

I would now like to turn the call over to Raffi Asadorian, Talphera's Chief Financial Officer. Please go ahead.

Raffi Asadorian
Chief Financial Officer

Thank you, and thank you for joining us on the call today.

Today, we announced our first quarter 2026 financial results and associated business updates in a press release. With me today are Vince Angotti, our Chief Executive Officer; and Dr. Shakil Aslam, Talphera's Chief Medical Officer.

Before we begin, I want to remind listeners that during this call, we will likely make forward-looking statements within the meaning of the federal securities laws. These forward-looking statements involve risks and uncertainties regarding the operations and future results of Talphera. Please refer to our press release in addition to the company's periodic current and annual reports filed with the SEC for a discussion of the risks associated with such forward-looking statements. These documents can also be found on the website within the Investors section.

I'll now hand the call over to Vince.

Vincent Angotti
CEO & Director

Thanks, Raffi. Good afternoon, and thank you to everyone joining our call today. It's been less than 2 months since our last update, and we're excited about the progress we've made this year in the NEPHRO study